Analysis of TI-6Al-4V Implants Place with Fibroblast Growth Factor 1 in Rat Tibiae

International Journal of Oral and Maxillofacial Implants

Volumn 16, Issue 4, 2001, Pages 495-502

  McCracken, Michael ^a   Lemons, Jack E ^a   Zinn, Kurt ^b  

^a Univ of Alabama School of Dentistry   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Dental implants; Fibroblast growth factor; Osseointegration; Radioimmunodetection

Indexed keywords

ALLOY; DIAGNOSTIC AGENT; DRUG CARRIER; FIBRIN GLUE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TITANIUM; TITANIUM ALLOY (TIAL6V4);

ANIMAL; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; BONE SCREW; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; IMAGE PROCESSING; MALE; MULTIVARIATE ANALYSIS; OSTEOBLAST; OSTEOTOMY; PATHOLOGY; RAT; SCINTILLATION CAMERA; SCINTISCANNING; SPRAGUE DAWLEY RAT; STATISTICS; SURFACE PROPERTY; TIBIA; WHOLE BODY COUNTING; WOUND HEALING;

ALLOYS; ANIMALS; BONE SCREWS; DRUG CARRIERS; FIBRIN TISSUE ADHESIVE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; GAMMA CAMERAS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MODELS, ANIMAL; MULTIVARIATE ANALYSIS; OSSEOINTEGRATION; OSTEOBLASTS; OSTEOGENESIS; OSTEOTOMY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS; SURFACE PROPERTIES; TECHNETIUM TC 99M MEDRONATE; TIBIA; TITANIUM; WHOLE-BODY COUNTING; WOUND HEALING;

EID: 0035403996     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Naert I, Quirynen M, van Steenberghe D, Darius P. A study of 589 consecutive implants supporting complete fixed prostheses. Part II: Prosthetic aspects. J Prosthet Dent 1992;68: 949-956.
2. Quirynen M, Naert I, van Steenberghe D, Nys L. A study of 589 consecutive implants supporting complete fixed prostheses. Part I: Periodontal aspects. J Prosthet Dent 1992;68: 655-663.
3. Saadoun AP, Le Gall MG. An 8-year compilation of clinical results obtained with Steri-Oss endosseous implants. Compendium 1996;17:669-674.
4. Zarb G, Schmitt A. The edentulous predicament II: The longitudinal effectiveness of implant-supported overdentures. J Am Dent Assoc 1996;127:66-72.
5. Albrektsson T, Dahl E, Enbom L, et al. Osseointegrated oral implants. A Swedish multicenter study of 8139 consecutively inserted Nobelpharma implants. J Periodontol 1988;59: 287-296.
6. Misch CE. Contemporary Implant Dentistry, ed 2. St Louis: Mosby, 1999.
7. Lynch SE, Buser D, Hernandez RA, et al. Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Periodontol 1991;62:710-716.
8. Howes R, Bowness JM, Grotendorst GR, Martin GR, Reddi AH. Platelet-derived growth factor enhances demineralized bone matrix-induced cartilage and bone formation. Calcif Tissue Int 1988;42:34-38.
9. Herr G, Hartwig CH, Boll C, Kusswetter W. Ectopic bone formation by composites of BMP and metal implants in rats. Acta Orthop Scand 1996;67:606-610.
10. Cole BJ, Bostrom MP, Pritchard TL, et al. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop 1997:219-228.
11. Wang X, Jin Y, Liu B, et al. Tissue reactions to titanium implants containing bovine bone morphogenetic protein: A scanning electron microscopic investigation. Int J Oral Maxillofac Surg 1994;23:115-119.
12. Xiang W, Baolin L, Yan J, Yang X. The effect of bone morphogenetic protein on osseointegration of titanium implants. J Oral Maxillofac Surg 1993;51:647-651.
13. Yan J, Xiang W, Baolin L, White FH. Early histologic response to titanium implants complexed with bovine bone morphogenetic protein. J Prosthet Dent 1994;71:289-294.
14. Kirker-Head CA, Gerhart TN, Armstrong R, Schelling SH, Carmel LA. Healing bone using recombinant human bone morphogenetic protein 2 and copolymer. Clin Orthop 1998 Apr;(349):205-217.
15. Gerhart TN, Kirker-Head CA, Kriz MJ, et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 1993 Aug;(293): 317-326.
16. Marden LJ, Hollinger JO, Chaudhari A, Turek T, Schaub RG, Ron E. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res 1994;28: 1127-1138.
17. Ono I, Ohura T, Murata M, Yamaguchi H, Ohnuma Y, Kuboki Y. A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. Plast Reconstr Surg 1992;90:870-879.
18. Mason IJ. The ins and outs of fibroblast growth factors. Cell 1994;78:547-552.
19. Gospodarowicz D, Neufeld G, Schweigerer L. Fibroblast growth factor. Mol Cell Endocrinol 1986;46:187-204.
20. Slavin J. Fibroblast growth factors: At the heart of angiogenesis. Cell Biol Int 1995;19:431-444.
21. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocrinol Rev 1987;8:95-114.
22. Aspenberg P, Tagil M, Kristensson C, Lidin S. Bone graft proteins influence osteoconduction. A titanium chamber study in rats. Acta Orthop Scand 1996;67:377-382.
23. Sela J, Shani J, Kohavi D, et al. Uptake and biodistribution of 99mtechnetium methylene-[32P] diphosphonate during endosteal healing around titanium, stainless steel and hydroxyapatite implants in rat tibial bone. Biomaterials 1995;16:1373-1380.
24. Masuda T, Salvi GE, Offenbacher S, Felton DA, Cooper LF. Cell and matrix reactions at titanium implants in surgically prepared rat tibiae. Int J Oral Maxillofac Implants 1997;12: 472-485.
25. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 1982; 11:318-326.
26. Robinson CJ. Growth factors: Therapeutic advances in wound healing. Ann Med 1993;25:535-538.
27. Lind M. Growth factors: Possible new clinical tools. A review. Acta Orthop Scand 1996;67:407-417.
28. Meyer-Ingold W. Wound therapy: Growth factors as agents to promote healing. Trends Biotech 1993;11:387-392.
29. Kiritsy CP, Lynch AB, Lynch SE. Role of growth factors in cutaneous wound healing: A review. Crit Rev Oral Biol Med 1993;4:729-760.
30. Wang JS, Aspenberg P. Basic fibroblast growth factor enhances bone-graft incorporation: Dose and time dependence in rats. J Orthop Res 1996;14:316-323.
31. Aspenberg P, Albrektsson T, Thorngren KG. Local application of growth-factor IGF-1 to healing bone. Experiments with a titanium chamber in rabbits. Acta Orthop Scand 1989;60:607-610.
32. Schliephake H, Jamil MU, Knebel JW. Experimental reconstruction of the mandible using polylactic acid tubes and basic fibroblast growth factor in alloplastic scaffolds. J Oral Maxillofac Surg 1998;56:616-626.
33. Wiltfang J, Merten HA. Ectopic bone formation with the help of growth factor βFGF. J Craniomaxillofac Surg 1996; 24:300-304.
34. Rodan SB, Wesolowski G, Thomas K, Rodan GA. Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. Endocrinology 1987;121:1917-1923.
35. Bland YS, Critchlow MA, Ashhurst DE. Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit. Acta Orthop Scand 1995;66:543-548.
36. Nakamura T, Hanada K, Tamura M, et al. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 1995;136:1276-1284.
37. Mayahara H, Ito T, Nagai H, et al. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 1993;9:73-80.